HOME /

News

Call for Proposals: 2022 HSCI Cancer Program Pilot Grants

February 2, 2022

AWARD AMOUNT
Up to $100,000 for entire project period
Project period not to exceed 2 years

POSTED DATE
Wednesday, February 2, 2022

DEADLINE FOR APPLICATION
Friday, March 4,  2022

ANTICIPATED AWARD DATE
April  1, 2022

The Harvard Stem Cell Institute (HSCI) Cancer Program invites applications for pilot grants to be awarded for research in 2022. The intent is to provide resources for innovative projects dissecting stem/developmental programs in solid tumors that would help foster collaborations within the HSCI research community. This funding is for innovative, high-impact research projects. Multi-investigator, multi-institution proposals are encouraged; of specific interest to this funding cycle are proposals that dissect mechanisms that enable malignant stem cells to evade the immune system. Additionally, the applications should promote the Program mission: To identify critical genes and pathways that sufficiently distinguish cancer from normal stem cells and hence may serve as candidate targets for therapy.... Read more about Call for Proposals: 2022 HSCI Cancer Program Pilot Grants

2022 Call for Applications: Barry Family HSCI Innovation Award for Early Investigators

January 31, 2022

AWARD AMOUNT: $250,000.00

DEADLINE FOR FULL APPLICATION: Friday, March 4, 2022

PRESENTATION TO SELECTION COMMITTEE (IF INVITED): Wednesday, April 20, 2022

ANTICIPATED AWARD DATE: Monday, June 6, 2022

HSCI is pleased to announce the third call for proposals for its annual award for innovation in the field of stem cell science and regenerative medicine.... Read more about 2022 Call for Applications: Barry Family HSCI Innovation Award for Early Investigators

Gut-brain connection in autism

January 7, 2022

Harvard and MIT researchers identify possible mechanism linking autism and intestinal inflammation

Many people with autism spectrum disorders also experience unusual gastrointestinal inflammation, but thus far scientists have not established whether and how those conditions might be linked.

Now, Harvard Stem Cell Institute (HSCI) researchers at Harvard Medical School, along with MIT researchers, may have found the missing link: infections during pregnancy can lead to high levels of the inflammatory signaling molecule interleukin-17a (...

Read more about Gut-brain connection in autism

Call for Proposals: 2022 HSCI Diabetes Program Pilot Grants - 'Targeted cargo delivery to pancreatic islet cells'

November 30, 2021

CALL FOR PROPOSALS

2022 HSCI DIABETES PROGRAM PILOT GRANTS

 

'Targeted cargo delivery to pancreatic islet cells'

 

AWARD AMOUNT

Up to $100,000 per year per lab for up to two years

 

POSTED DATE

December 6, 2021

 

DEADLINE FOR APPLICATION

January 28, 2022

 

ANTICIPATED AWARD DATE

April 1, 2022

 

The Harvard Stem Cell Institute (HSCI) Diabetes Program invites applications for pilot grant funding. The purpose of this call for applications is to fund innovative projects that aim to develop new or leverage existing modalities to deliver genetic payloads to pancreatic islet cells for the therapy of type 1 diabetes. Collaborative proposals are welcome, particulary where one of the labs has expertise in diabetes research. The HSCI diabetes Program intends to award up to two grants in response to this call for proposals, contingent upon the number and quality of the proposals received.... Read more about Call for Proposals: 2022 HSCI Diabetes Program Pilot Grants - 'Targeted cargo delivery to pancreatic islet cells'

Call for Proposals: 2022 HSCI Diabetes Program Pilot Grants - 'Learning from cancer immunology to cure autoimmune diabetes'

November 30, 2021

CALL FOR PROPOSALS

2022 HSCI DIABETES PROGRAM PILOT GRANTS

 

'Learning from cancer immunology to cure autoimmune diabetes'

 

AWARD AMOUNT

Up to $100,000 per year per lab for up to two years

 

POSTED DATE

December 6, 2021

 

DEADLINE FOR APPLICATION

January 28, 2022

 

ANTICIPATED AWARD DATE

April 1, 2022

 

The Harvard Stem Cell Institute (HSCI) Diabetes Program invites applications for pilot grant funding. The purpose of this call for applications is to fund innovative projects rooted in our understanding of tumor-immune interactions to avert the immune attack on pancreatic islet cells that underlies type 1 diabetes. A particular focus of the Diabetes Program lies in developing solutions that will enable the transplantation of stem cell-derived islet cells into patients with autoimmune diabetes. Approaches of interest include – but are not limited to – novel immune interventions to regulate or eliminate autoreactive T lymphocytes, interventions to modify local antigen presentation, and genetic manipulations of stem cell-derived islet cells to protect them against allo- and autoimmunity. Collaborative proposals are welcome, particulary where one of the labs has expertise in diabetes research. The HSCI diabetes Program intends to award up to two grants as a result of this call for proposals.... Read more about Call for Proposals: 2022 HSCI Diabetes Program Pilot Grants - 'Learning from cancer immunology to cure autoimmune diabetes'